ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672045 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672045; 2) Community: the network communities that were significantly associated with the response to NSC 672045; 3) Molecule: the relationships between components within communities and NSC 672045; 4) MDR: the compounds that were significantly associated with the NSC 672045.

NSC Compound Enrichment Correlation
NSC 690043 Null 0.0019895000709106 0.39770864
NSC 699491 Epidoxoform 0.0019895000709106 0.28139881
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0019895000709106 0.49744299
NSC 760979 Null 0.0019895000709106 0.20083675
NSC 301457 Cycloalkannin 0.00211131723826695 0.77917108
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.00211131723826695 0.70508926
NSC 626162 Discorhabdin C . TFA 0.00211131723826695 0.74628525
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.00211131723826695 0.6491538
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00211131723826695 0.7355858
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.00211131723826695 0.3585302
Total:132  Current:13    [First] [Prev] [Next] [Last]